Cencora (WBO:ABC) Long-Term Debt: €10,604 Mil (As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
67 GF Score
Price €256.60
GF Value €252.90
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Long-Term Debt?

Cencora WBO:ABC +2.15% 67 Long-Term Debt is €10,604 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 67/100 and a GF Value™ of €252.90 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Long-Term Debt for the quarter that ended in Mar. 2026 was €10,604 Mil.

Cencora's quarterly Long-Term Debt increased from Sep. 2025 (€6,427 Mil) to Dec. 2025 (€6,473 Mil) and increased from Dec. 2025 (€6,473 Mil) to Mar. 2026 (€10,604 Mil).

Cencora's annual Long-Term Debt declined from Sep. 2023 (€3,885 Mil) to Sep. 2024 (€3,434 Mil) but then increased from Sep. 2024 (€3,434 Mil) to Sep. 2025 (€6,427 Mil).

Cencora  (WBO:ABC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Cencora Long-Term Debt Related Terms

Cencora Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Cencora's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Long-Term Debt Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,426.15 4,678.68 3,884.91 3,434.38 6,426.63

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,605.50 7,086.69 6,426.63 6,472.86 10,604.13
WBO:ABC
67GF Score
Cencora Inc WBO:ABC
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €10,604 Mil mean?
Cencora (WBO:ABC) has a Long-Term Debt of €10,604 Mil as of Mar. 2026.
Is Cencora's Long-Term Debt too high?
Cencora's current Long-Term Debt is €10,604 Mil. Overall, Cencora has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Long-Term Debt compare to CAH and MCK?
Cencora's Long-Term Debt of €10,604 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Cencora's current Long-Term Debt is €10,604 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €252.90, compared to a current price of €256.60 — trading 1.5% above its estimated fair value. The current Long-Term Debt is €10,604 Mil. Cencora's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Long-Term Debt is €10,604 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €256.60 is trading 1.5% above its estimated GF Value™ of €252.90. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Long-Term Debt: €10,604 Mil
  • GF Value™: €252.90 vs. price of €256.60 (1.5% above fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
67GF Score

Get the complete analysis for WBO:ABC

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€256.60
Price
€252.90
GF Value